November, 2023

Remove insurance-fda
article thumbnail

AMA urges coverage of obesity treatments as payers balk at costs

STAT

WASHINGTON – The American Medical Association called on insurance companies, employers, and government programs to cover obesity treatments even as many remain reluctant to pay for them, fearing the costs of covering the drugs at a mass scale. ” Read the rest…

Insurance 144
article thumbnail

STAT+: Pharmalittle: AMA calls for obesity drug coverage; Covid rebound may be more common with Paxlovid than without

STAT

… The American Medical Association called on insurance companies, employers, and government programs to cover obesity treatments even as many remain reluctant to pay for them, fearing the costs of covering the drugs at a mass scale, STAT writes. We hope you have a smashing day and, of course, do stay in touch. Reuters notes.

Insurance 126
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA approves Zepbound for weight loss

The Checkup by Singlecare

Food and Drug Administration (FDA) just approved Zepbound (tirzepatide) for chronic weight management. The injectable medication is a new version of Eli Lilly’s Mounjaro, which is approved by the FDA to control blood sugar in people with Type 2 diabetes. Zepbound, on the other hand, has been FDA-approved for weight loss.

FDA 120
article thumbnail

How much is Creon without insurance?

The Checkup by Singlecare

Is Creon covered by insurance? | How much does Creon cost without insurance? | How to get Creon without insurance Creon is a brand-name prescription drug that contains digestive enzymes to break down basic components of what people eat. Is Creon covered by insurance? How much does Creon cost without insurance?

article thumbnail

4 benefits of GLP-1 drugs

The Checkup by Singlecare

If a drug is FDA approved for a particular purpose, that means the Food and Drug Administration (FDA) has deemed the drug to be effective for that purpose, based on reviewing extensive data from clinical trials supporting its use. As of the time of this writing, semaglutide is not yet FDA-approved for this specific purpose.

article thumbnail

Guide to Medicaid in New York

The Checkup by Singlecare

These include the following: Adults 19-64 years of age who are not eligible for Medicare Children 1-18 years of age Infants (younger than 1) Youth in foster care and former foster care youth Children not eligible for Medicaid may be able to get coverage through Child Health Plus , an expanded health insurance program.

article thumbnail

Shrinking COVID vaccine sales has Moderna course-correcting

STAT

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. There’s potential that a stem cell infusion from kidney donors might help prevent organ rejection — allowing patients to perhaps wean from immunosuppressive drugs.

Vaccines 115